PROCTER & GAMBLE HEALTH LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,662 INR | -1.72% |
|
-3.16% | -5.77% |
| May. 03 | Procter & Gamble Health's Profit Declines in Fiscal Q3 | MT |
| May. 02 | Procter & Gamble Health Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 11.14B 134M | Sales 2023 | 12.3B 147M | Capitalization | 87.13B 1.04B |
|---|---|---|---|---|---|
| Net income 2022 | 1.92B 23.06M | Net income 2023 | 2.3B 27.49M | EV / Sales 2022 | 5.95 x |
| Net cash position 2022 | 3.17B 37.93M | Net cash position 2023 | 4.23B 50.68M | EV / Sales 2023 | 6.74 x |
| P/E ratio 2022 |
36.1
x | P/E ratio 2023 |
38
x | Employees | 1,407 |
| Yield 2022 |
1.25% | Yield 2023 |
1.81% | Free-Float | 47.83% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.72% | ||
| 1 week | -3.16% | ||
| Current month | -5.04% | ||
| 1 month | -3.40% | ||
| 3 months | -15.15% | ||
| 6 months | -9.80% | ||
| Current year | -5.77% |
1 week
4 639.25
4 799.00
1 month
4 636.554 988.75
Current year
4 636.555 642.85
1 year
4 575.005 642.85
3 years
3 870.106 100.00
5 years
2 891.457 500.00
10 years
611.057 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
Milind Thatte
CEO | Chief Executive Officer | 55 | 18-03-31 |
Lokesh Chandak
DFI | Director of Finance/CFO | - | 23-03-31 |
Zeal Shah
CMP | Compliance Officer | - | 21-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 86 | 84-01-16 | |
| Director/Board Member | 66 | 21-11-14 | |
Rani Ajit Jadhav
BRD | Director/Board Member | 75 | 15-02-04 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 4,662 | -1.72% | 9,933 |
| 24-05-08 | 4,744 | -0.09% | 49,841 |
| 24-05-07 | 4,749 | +1.05% | 12,728 |
| 24-05-06 | 4,699 | -1.08% | 11,626 |
| 24-05-03 | 4,751 | -1.33% | 32,440 |
End-of-day quote NSE India S.E., May 08, 2024
More quotes
Procter & Gamble Health Limited is an India-based company that is primarily engaged in the manufacturing of pharmaceutical products. The Company is engaged in the manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Companyâs brands include Cosome, Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Evion range has different variants with different levels of Vitamin E, such as Evion 400, Evion 200, and Evion 600. Neurobion offers a range of neurotropic B-Vitamins which are a combination to help treat nerve damage and regenerate the nerves to relieve symptoms. Nasivion Classic Nasal Spray starts working on a blocked nose in 25 seconds. Polybion is a brand that helps with release and hence supports an active life.
Sector
Pharmaceuticals
Calendar
2024-08-21
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +19.62% | 42.97B | |
| +24.52% | 22.49B | |
| +19.36% | 14.93B | |
| +7.48% | 13.14B | |
| +42.51% | 11.67B | |
| -8.84% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.13% | 5.54B |
- Stock Market
- Equities
- PGHL Stock
- PGHL Stock